The global demand for Mammalian Cell Fermentation Technology Market is presumed to reach the market size of nearly USD 83.61 BN by 2030 from USD 40.6 BN in 2022 with a CAGR of 9.45% under the study period 2023 - 2030.
Mammalian cell fermentation technology, often referred to as mammalian cell culture or simply cell culture, is a biotechnology process used for the growth, maintenance, and manipulation of mammalian cells in a controlled environment. This technology is a fundamental tool in the fields of biopharmaceuticals, regenerative medicine, basic research, and various other areas of biology and medicine. It involves the cultivation of cells derived from mammals, such as humans, mice, or Chinese hamsters, under carefully controlled conditions to produce specific biological products or to study cellular behavior and functions.
The mammalian cell fermentation technology market is being driven by several factors. The biopharmaceutical industry's rapid growth, fueled by the demand for biologics like monoclonal antibodies and vaccines, has significantly contributed to the expansion of this market. Monoclonal antibody production, in particular, has surged, leading to increased reliance on mammalian cell culture processes. Advancements in gene and cell therapies, as well as vaccine production, have further boosted the demand for this technology. The COVID-19 pandemic accelerated the need for efficient vaccine development and production, resulting in substantial investments and innovations in mammalian cell fermentation. Bioprocess optimization and cost-reduction efforts have led to the adoption of high-yield cell lines and innovative culture techniques. Government initiatives and regulatory support for biopharmaceuticals have encouraged investments in this technology, while ongoing technological advancements have improved scalability and cost-effectiveness. Emerging markets, especially in developing economies, are witnessing significant growth as they seek affordable biopharmaceutical solutions. Additionally, mammalian cell culture technology plays a crucial role in regenerative medicine and tissue engineering, further expanding its applications.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mammalian cell fermentation technology. The growth and trends of mammalian cell fermentation technology industry provide a holistic approach to this study.
This section of the mammalian cell fermentation technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Application
By End-Use
This section covers the regional outlook, which accentuates current and future demand for the Mammalian Cell Fermentation Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Mammalian Cell Fermentation Technology market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher, Lonza, F. Hoffmann-La Roche Ltd, Sartorius AG, AstraZeneca, Bristol-Myers Squibb, Amgen, Gilead Sciences, Moderna Inc., Regeneron Pharmaceuticals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . MAMMALIAN CELL FERMENTATION TECHNOLOGY – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-Use
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Chinese Hamster Ovary (CHO) Cell Fermentation Historic and Forecast Sales by Regions
5.5 Human Embryonic Kidney (HEK) Cell Fermentation Historic and Forecast Sales by Regions
5.6 BaHamster Kidney (BHK) Cell Fermentation Historic and Forecast Sales by Regions
5.7 Murine Myeloma Cell Fermentation Historic and Forecast Sales by Regions
5.8 Others Historic and Forecast Sales by Regions
6 . GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
&nb ...